Belite-Bio-Logo Digital-Full-Color.png
Belite Bio Reports First Half 2022 Operational Highlights and Financial Results
August 10, 2022 21:51 ET | Belite Bio, Inc
 -LBS-008 (aka Tinlarebant) is Belite Bio’s orally administered tablet for the treatment of Stargardt disease (STGD1) and Dry AMD -A 2-year Phase 2 trial in adolescent STGD1 and a global Phase 3 trial...
Verona_Pharma_Dark_medium.jpg
Verona Pharma plc Announces Pricing of Upsized Underwritten Public Offering
August 10, 2022 20:22 ET | Verona Pharma plc
LONDON and RALEIGH, N.C., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage biopharmaceutical company focused on respiratory...
Aveanna Healthcare Holdings Announces Second-Quarter 2022 Financial Results
August 10, 2022 19:12 ET | Aveanna Healthcare Holdings, Inc
ATLANTA, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings, Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost...
Aziyo Logo.jpg
Aziyo Biologics Announces $25 Million Loan Facility with SWK Holdings
August 10, 2022 18:56 ET | Aziyo Biologics
SILVER SPRING, Md., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (the “Company”), a commercial-stage regenerative medicine company announced today that it has entered into...
SovosBrands_Logo_Red_CMYK.jpg
Sovos Brands Announces Pricing of Secondary Public Offering
August 10, 2022 18:38 ET | Sovos Brands, Inc.
LOUISVILLE, Colo., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Sovos Brands, Inc. (“Sovos Brands”) (Nasdaq: SOVO), one of the fastest growing food companies of scale in the United States, announced today the...
Skylight-Health-Horiz1-Signature-Teal.png
Skylight Health Announces Timing of its Second Quarter 2022 Results Conference Call
August 10, 2022 17:30 ET | Skylight Health Group Inc.
TORONTO, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG; TSXV:SLHG) (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States,...
Rani-Logo.jpg
Rani Therapeutics Announces Proposed Public Offering of Class A Common Stock
August 10, 2022 17:28 ET | Rani Therapeutics, LLC
SAN JOSE, Calif., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of...
120114 PONO Capital.png
Pono Capital Corp Confirms Funding to Extend Period to Consummate Initial Business Combination
August 10, 2022 17:25 ET | Pono Capital Corp.
Honolulu, Hawaii, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Pono Capital Corp (the “Company”) (Nasdaq: PONO), a special purpose acquisition company, today announced that Mehana Capital LLC, an affiliate of...
120114 PONO Capital.png
Pono Capital Corp Announces Termination of Merger Agreement with Benuvia, Inc.
August 10, 2022 17:25 ET | Pono Capital Corp.
Honolulu, Hawaii, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Pono Capital Corp (NASDAQ: PONO) (the “Company” or “Pono”), a special purpose acquisition company, announced today that it has terminated its...
Hainan Manaslu Acquisition Corp. Announces Pricing of $60.0 Million Initial Public Offering
August 10, 2022 17:22 ET | Hainan Manaslu Acquisition Corp.
NEW YORK, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Hainan Manaslu Acquisition Corp. (Nasdaq: HMACU) (“the “Company”), a Cayman Islands exempted company formed for the purpose of effecting a merger, share...